Depo-provera |
|
|
Depo-provera Clinical Trials
- Depo-Provera: Evaluation of BMDensity and Total Body Ca Adolescent DP150CI Users and Non-Hormonal Contraception
ClinicalTrials.gov Identifier: NCT00139685 - Active, not recruiting
Contraception; Bone Density
- Pilot Study of Femring Estrogen Supplementation During Depo-Provera Initiation
ClinicalTrials.gov Identifier: NCT00563576 - Recruiting
Metrorrhagia
- Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use with Certain Anti-HIV Drugs in HIV-Infected Women
ClinicalTrials.gov Identifier: NCT00016601 - Completed
HIV Infections
- Manipulation of the Intratesticular Hormonal Milieu with Exogenous Testosterone (HOP 5) Testicular Aspiration Addendum
ClinicalTrials.gov Identifier: NCT00156650 - Completed
Contraception
- A Study of the Safety and Efficacy of Synvisc and Depo-Medrol in Patients with Osteoarthritis of the Hip.
ClinicalTrials.gov Identifier: NCT00131326 - Completed
osteoarthritis of the hip; musculoskeletal
- Safety of Estrogens in Lupus: Hormone Replacement Therapy
ClinicalTrials.gov Identifier: NCT00000419 - Terminated
Systemic Lupus Erythematosus
- Hormonal Contraception and Risk of Chlamydia and Gonorrhea
ClinicalTrials.gov Identifier: NCT00091728 - Terminated
Chlamydia Infection; Neisseriaceae Infection

Not Signed In -


